Identifying the subtypes of hypertonia is becoming increasingly important. Treatment strategies, including tone-modulating surgical interventions, medication type and dosing, and chemodenervation, may differ depending on the type of hypertonia present. It is important to delineate how hypertonia interferes with function and quality of life so that the appropriate intervention can be selected at the right time. Outcomes of treatment depend heavily on clear communication of goals. Botulinum toxin should not be used in isolation but as an adjunct to rehabilitation modalities.
Keywords: Botulinum toxin; Chemodenervation; Dystonia; Goal setting; Hypertonia; Phenol; Spasticity.
Copyright © 2019 Elsevier Inc. All rights reserved.